Correction to : Characteristics and outcomes of COVID-19 patients during the BA.5 omicron wave in Tehran, Iran: a prospective observational study
| Errataetall: |
ErratumFor: BMC Infect Dis. 2023 Apr 17;23(1):237. - PMID 37069563 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
BMC infectious diseases - 23(2023), 1 vom: 07. Aug., Seite 516 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Salehi, Mohammadreza [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 22.11.2023 published: Electronic ErratumFor: BMC Infect Dis. 2023 Apr 17;23(1):237. - PMID 37069563 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s12879-023-08507-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360502717 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360502717 | ||
| 003 | DE-627 | ||
| 005 | 20231226083142.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12879-023-08507-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1201.xml |
| 035 | |a (DE-627)NLM360502717 | ||
| 035 | |a (NLM)37550617 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Salehi, Mohammadreza |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to |b Characteristics and outcomes of COVID-19 patients during the BA.5 omicron wave in Tehran, Iran: a prospective observational study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 22.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumFor: BMC Infect Dis. 2023 Apr 17;23(1):237. - PMID 37069563 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Khaneshan, Arezoo Salami |e verfasserin |4 aut | |
| 700 | 1 | |a Farahani, Abbas Shakoori |e verfasserin |4 aut | |
| 700 | 1 | |a Doomanlou, Mahsa |e verfasserin |4 aut | |
| 700 | 1 | |a Arabzadeh, Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Sobati, Abolfazl |e verfasserin |4 aut | |
| 700 | 1 | |a Farhadi, Kousha |e verfasserin |4 aut | |
| 700 | 1 | |a Fattahi, Reza |e verfasserin |4 aut | |
| 700 | 1 | |a Mohammadnejad, Esmaeil |e verfasserin |4 aut | |
| 700 | 1 | |a Abdoli, Asghar |e verfasserin |4 aut | |
| 700 | 1 | |a Zebardast, Jayran |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC infectious diseases |d 2001 |g 23(2023), 1 vom: 07. Aug., Seite 516 |w (DE-627)NLM11120089X |x 1471-2334 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:1 |g day:07 |g month:08 |g pages:516 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12879-023-08507-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 1 |b 07 |c 08 |h 516 | ||